← Browse by Condition
Medical Condition
cognitive decline
Total Trials
11
Recruiting Now
11
Trial Phases
Phase 2, Phase 3
ClinicalMetric tracks all active clinical trials for cognitive decline sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — cognitive decline Clinical Trials
How many clinical trials are currently recruiting for cognitive decline?
ClinicalMetric currently tracks 11 actively recruiting clinical trials for cognitive decline, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 11. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cognitive decline?
cognitive decline research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cognitive decline clinical trial?
Eligibility criteria for cognitive decline trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 1
Phase 3 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT07226674
Recruiting
Enrollment
100 pts
Location
United Kingdom
Sponsor
University of Ulster
NCT04390646 Phase 2, Phase 3
Recruiting
Enrollment
56 pts
Location
Switzerland
Sponsor
Nelly Pitteloud
NCT07182396
Recruiting
Enrollment
34 pts
Location
Pakistan
Sponsor
Foundation University Islamaba...
NCT02972008
Recruiting
Enrollment
542 pts
Location
France
Sponsor
University Hospital, Lille
NCT07399418
Recruiting
Enrollment
80 pts
Location
Italy
Sponsor
Istituti Clinici Scientifici M...
NCT06290167
Recruiting
Enrollment
90 pts
Location
Italy
Sponsor
Istituto Auxologico Italiano
NCT05592678
Recruiting
Enrollment
200 pts
Location
United States
Sponsor
The University of Texas Health...
NCT04635657
Recruiting
Enrollment
50 pts
Location
United States
Sponsor
Ohio State University
NCT06124339
Recruiting
Enrollment
150 pts
Location
United States
Sponsor
University of California, San ...
NCT07127965
Recruiting
Enrollment
226 pts
Location
United States
Sponsor
University of Colorado, Boulde...
NCT05114876
Recruiting
Enrollment
260 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology